David V. Power

University of Minnesota — United States

Medicine · Health Sciences

22h-index14.1kcitations90works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Innovations in Medical Education(25), Medical Education and Admissions(15), Healthcare professionals’ stress and burnout(10), Global Health Workforce Issues(8), Palliative Care and End-of-Life Issues(4)

Publications90 total

Teaching communication skills while supervising in the patient's presence
Patient Education and Counseling·2025
Impact of lesion location and SYNTAX score breakdown on patients undergoing percutaneous left main revascularization
Cardiovascular revascularization medicine·2025· 1 cited
Patient-Identified Barriers to Hepatitis C Treatment
PRiMER·2025Open Access
Significance of diabetes mellitus status in patients undergoing percutaneous left main coronary artery intervention
Catheterization and Cardiovascular Interventions·2024· 1 citedOpen Access
Courage to Shape Our Future
Family Medicine·2024· 1 citedOpen Access
Current Procedural Practices of Family Medicine Teaching Physicians
Family Medicine·2024· 3 citedOpen Access
Teachers’ perspectives on communication in the context of supervising learners during telehealth encounters
Qualitative Health Communication·2023· 1 citedOpen Access
What is the risk of extrapyramidal symptoms in patients taking aripiprazole?
Evidence-Based Practice·2022· 2 cited
Imaging in Percutaneous Coronary Intervention
Reviews in Cardiovascular Medicine·2022Open Access
CE-543-04 INTER-ATRIAL BLOCK IDENTIFIES PATIENTS WITH LOW CHA2DS2-VASC SCORE BUT HIGH STROKE RISK
Heart Rhythm·2022
IMPACT OF CHRONIC THROMBOCYTOPENIA ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIAL
Journal of the American College of Cardiology·2022
IMPACT OF CORONARY ARTERY DISEASE ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIAL
Journal of the American College of Cardiology·2022· 2 cited
Is a serotonin–norepinephrine reuptake inhibitor superior to an SSRI in the treatment of major depressive disorder in adults?
Evidence-Based Practice·2021
Reckoning with History: M Health Fairview’s journey to remove race from estimated glomerular filtration calculation
2021
The Unintended Consequences of Adverse Event Information on Medicines’ Risks and Label Content
Pharmaceutical Medicine·2020· 1 cited
Results of a Preceptor Improvement Project
Family Medicine·2020· 6 citedOpen Access
485-P: T Lymphocytes Infiltration in Kidneys of People with Type 2 Diabetes
Diabetes·2020
What are the best treatments for intellectually disabled patients with aggression?
Evidence-Based Practice·2020
OP56 The cost-effectiveness of advance care planning for older adults with end-stage kidney disease
Oral Presentations·2019Open Access
The personalities of most medical students are suited to rural practice: Implications for rural education program recruitment
Medical Teacher·2019· 8 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Liselotte N. Dyrbye(12), Matthew R. Thomas(12), F. Stanford Massie(12), Anne Eacker(12), William R. Harper(12), Tait D. Shanafelt(12), Jeff A. Sloan(9), Steven J. Durning(7), Christine Moutier(7), Daniel Szydlo(5), Daniel Satele(4), Paul J. Novotny(3), Kathleen D. Brooks(3), Michael Kearney(2), Therese Zink(2), Ilene Harris(2), Dianna Shandy(2), Marcy Rosenbaum(2), Darin Brink(2), Davide Cao(2)